Overview
- Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients
- Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)
- Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers
- Includes supplementary material: sn.pub/extras
Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 195)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (22 chapters)
-
Introduction
-
Minimal residual disease and breast cancer metastasis
-
Technologies for circulating tumor cell (CTC) and disseminated tumor cell (DTC) detection and characterization
Keywords
About this book
Editors and Affiliations
Bibliographic Information
Book Title: Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Editors: Michail Ignatiadis, Christos Sotiriou, Klaus Pantel
Series Title: Recent Results in Cancer Research
DOI: https://doi.org/10.1007/978-3-642-28160-0
Publisher: Springer Berlin, Heidelberg
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2012
Hardcover ISBN: 978-3-642-28159-4Published: 23 April 2012
Softcover ISBN: 978-3-642-44587-3Published: 09 May 2014
eBook ISBN: 978-3-642-28160-0Published: 23 April 2012
Series ISSN: 0080-0015
Series E-ISSN: 2197-6767
Edition Number: 1
Number of Pages: XIV, 254
Topics: Oncology, Gynecology, Surgical Oncology, Pathology, Cancer Research